Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Orion Corporation OY (OTC: ORINY).

Full DD Report for ORINY

You must become a subscriber to view this report.


Recent News from (OTC: ORINY)

Orion Corporation OY ADR 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Orion Corporation OY ADR in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: July, 19 2018 13:57
59 Top-Yield Healthcare Equities For June
Actionable Conclusions (1-10): Analysts Projected 6% To 23% Net Gains For Top Ten Healthcare Stocks By June 2019 Just two of ten top dividend-yielding Healthcare stocks were verified as being among the top ten gainers for the coming year, based on broker 1-year target prices. (They a...
Source: SeekingAlpha
Date: June, 26 2018 05:02
50 Healthcare Top Yield Equities For April
Actionable Conclusions (1-10): Analysts Predicted 9.8% To 41.2% Net Gains For Top Ten Healthcare Equities By April 2019 Two of ten top dividend-yielding Healthcare stocks were verified as being among the top ten gainers for the coming year based on analyst 1-year target prices. ...
Source: SeekingAlpha
Date: April, 10 2018 09:58
Healthcare Top Gainers: Sanofi, Merck, Glaxo, Patterson, And AstraZeneca By Broker February Targets
Actionable Conclusions (1-10): Analysts Predicted 4.22% To 26.43% Net Gains For Top Ten Healthcare Equities By February 2019 Four of ten top dividend-yielding Healthcare stocks were verified as being among the top ten gainers for the coming year based on analyst 1-year target prices. (...
Source: SeekingAlpha
Date: March, 01 2018 14:28
Healthcare Net Gains Leaders For 2018 Are Glaxo, Sanofi, Merck, Owens, Novartis, And Pfizer Per Broker Targets
Actionable Conclusions (1-10): Analysts Predicted 3.18% To 23.18% Net Gains For Top Ten Healthcare Dogs By December 2018 Six of ten top dividend-yielding Healthcare dogs were verified as being among the top ten gainers for the coming year based on analyst 1-year target prices. (They ...
Source: SeekingAlpha
Date: December, 29 2017 01:26

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A16.35N/AN/A0
2018-12-13N/A16.35N/AN/A0
2018-12-12N/A16.35N/AN/A0
2018-12-1116.3516.3516.3516.35400
2018-12-10N/A17.28N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-0211151121.7221Cover
2018-08-0128938974.2931Short
2018-07-27100100100.0000Short
2018-04-251515100.0000Short
2018-04-04153050.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ORINY.


About Orion Corporation OY (OTC: ORINY)

Logo for Orion Corporation OY (OTC: ORINY)

Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests a builder of well being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R amp D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. lt br / gt lt br / gt Orion s net sales in amounted to EUR million and the company had about , employees. Orion s A and B shares are listed on NASDAQ OMX Helsinki.

 

Contact Information

 

 

Current Management

  • Jari Karlson / CFO
  • Heidi Ahti / Head of IR
  • Susanna Siira / IR Manager

Current Share Structure

  • Market Cap: $3,155,642,183 - 03/16/2018
  • Issue and Outstanding: 98,985,012 - 07/24/2013

 



Daily Technical Chart for (OTC: ORINY)

Daily Technical Chart for (OTC: ORINY)


Stay tuned for daily updates and more on (OTC: ORINY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ORINY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ORINY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ORINY and does not buy, sell, or trade any shares of ORINY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/